| Q4 2015 |
793 |
$678,118,000 |
+$255,359,581 |
-$152,736,655 |
+$102,622,926 |
XOM, MAIN, XLP, AGG, IEF
|
13F-HR |
16 Feb 2016, 09:46 |
| Q3 2015 |
1,009 |
$566,974,000 |
+$167,678,165 |
-$18,369,893 |
+$149,308,272 |
XOM, MAIN, AAPL, EPD, MCD
|
Restatement |
30 Nov 2015, 13:56 |
| Q2 2015 |
736 |
$474,057,000 |
+$32,277,454 |
-$202,224,247 |
-$169,946,793 |
XOM, MAIN, MEMPQ, AAPL, IDV
|
13F-HR |
28 Jul 2015, 16:55 |
| Q1 2015 |
1,006 |
$665,517,318 |
+$27,723,661 |
-$29,475,604 |
-$1,751,943 |
XOM, MAIN, MEMPQ, SPY, AAPL
|
13F-HR |
19 May 2015, 15:20 |
| Q4 2014 |
1,051 |
$667,964,747 |
+$102,356,638 |
-$290,036,274 |
-$187,679,636 |
XOM, MAIN, MEMPQ, SPY, AAPL
|
13F-HR |
18 Feb 2015, 10:29 |
| Q3 2014 |
1,073 |
$902,000,000 |
+$314,560,521 |
-$240,755,499 |
+$73,805,022 |
XOM, PDL BIOPHARMA INC, MAIN, COLONY FINL INC, ARES CAP CORP
|
13F-HR |
13 Nov 2014, 16:05 |
| Q2 2014 |
1,019 |
$860,191,000 |
+$305,569,327 |
-$238,109,403 |
+$67,459,924 |
XOM, PDL BIOPHARMA INC, COLONY FINL INC, ARES CAP CORP, PROSPECT CAPITAL CORPORATION
|
13F-HR |
07 Aug 2014, 21:26 |
| Q1 2014 |
975 |
$780,734,000 |
+$146,913,651 |
-$98,841,141 |
+$48,072,510 |
XOM, PDL BIOPHARMA INC, PROSPECT CAPITAL CORPORATION, MAIN, SPY
|
13F-HR |
16 May 2014, 06:35 |
| Q4 2013 |
975 |
$731,061,000 |
$0 |
$0 |
$0 |
XOM, PROSPECT CAPITAL CORPORATION, SPY, MAIN, ARES CAP CORP
|
13F-HR |
11 Feb 2014, 21:44 |